Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Blueprint Medicines (BPMC) Prices 4.054M Share Common Offering at $74/ShMarch 29, 2019 5:47 AM Blueprint Medicines Announces Accelerated Regulatory Submission Plans and Recent Clinical ProgressMarch 27, 2019 4:00 PM